Merck to buy Avecia Biologics
Merck & Co. has agreed to acquire Avecia Biologics, a contract manufacturing organization specializing in microbial-derived biologics. Financial terms of the deal weren’t disclosed. Under the agreement, made with Avecia Investments Ltd.